A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

Having depression is known to increase a person’s risk of developing dementia, but depression is also an early indicator of ...

In addition to its CNS focus, Jupiter is evaluating opportunities in longevity and metabolic health. Emerging data suggests that JOTROL's inhibition of NLRP3, when combined with GLP-1 treatments, ...

IGC Pharma, Inc (NYSE American:IGC) (”IGC” or the “Company”), today announced that CEO Ram Mukunda and CCO Claudia Grimaldi ...

Mild chronic small vessel disease, or cerebral small vessel disease (CSVD), is an umbrella term for a range of conditions ...

NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a ...

The Phase Ia trial is designed to assess the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

Gum disease appears to disrupt brain activity, potentially increasing a person’s risk of cognitive decline.People with ...

Knowing the warning signs of dementia is important for dealing with the debilitating condition that currently has no cure.

Cognitive problems like more diminished attention, but better immediate recall and memory may help predict Lewy body dementia ...

Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...